DE69832070D1 - Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region - Google Patents

Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region

Info

Publication number
DE69832070D1
DE69832070D1 DE69832070T DE69832070T DE69832070D1 DE 69832070 D1 DE69832070 D1 DE 69832070D1 DE 69832070 T DE69832070 T DE 69832070T DE 69832070 T DE69832070 T DE 69832070T DE 69832070 D1 DE69832070 D1 DE 69832070D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
drug administration
olfactory region
packaging unit
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69832070T
Other languages
English (en)
Other versions
DE69832070T2 (de
Inventor
Sveinbjoern Gizurarson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LYFJATHROUN BIOPHARMACEUTICALS HF., REYKJAVIK, IS
Original Assignee
Sveinbjoern Gizurarson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69832070(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sveinbjoern Gizurarson filed Critical Sveinbjoern Gizurarson
Publication of DE69832070D1 publication Critical patent/DE69832070D1/de
Application granted granted Critical
Publication of DE69832070T2 publication Critical patent/DE69832070T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
DE69832070T 1997-07-01 1998-07-01 Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region Revoked DE69832070T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform
IS451697 1997-07-01
PCT/DK1998/000297 WO1999001229A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region

Publications (2)

Publication Number Publication Date
DE69832070D1 true DE69832070D1 (de) 2005-12-01
DE69832070T2 DE69832070T2 (de) 2006-07-13

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832070T Revoked DE69832070T2 (de) 1997-07-01 1998-07-01 Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region

Country Status (10)

Country Link
US (1) US6647980B1 (de)
EP (1) EP0991479B1 (de)
AT (1) ATE307676T1 (de)
AU (1) AU739893B2 (de)
CA (1) CA2298596A1 (de)
DE (1) DE69832070T2 (de)
DK (1) DK0991479T3 (de)
ES (1) ES2255165T3 (de)
IS (1) IS4516A (de)
WO (1) WO1999001229A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7465287B2 (en) * 2001-02-08 2008-12-16 Nasaleze Patents Limited Apparatus for dispensing powdered material
WO2003070273A1 (en) * 2002-02-25 2003-08-28 Lyfjathroun Hf A bioadhesive agent
CA2484592A1 (en) 2002-05-09 2003-11-20 Glaxo Group Limited A fluid dispensing device
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
US20050070460A1 (en) 2003-08-05 2005-03-31 3M Innovative Properties Company Infection prophylaxis using immune response modifier compounds
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
EP1699512B1 (de) 2003-11-03 2012-06-20 Glaxo Group Limited Fluidabgabevorrichtung
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
WO2007064657A1 (en) * 2005-11-29 2007-06-07 Alza Corporation Nasal delivery device for the delivery of a substance to the olfactory region
WO2007083073A1 (en) * 2006-01-19 2007-07-26 Optinose As Nasal administration
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) * 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
MX2009011938A (es) * 2007-05-04 2009-11-13 Procter & Gamble Composiciones antimicrobianas, productos y metodos de uso.
JP2011511674A (ja) 2008-02-07 2011-04-14 ユニヴァーシティ オブ ワシントン 周方向エアロゾルデバイス
US8718754B2 (en) 2009-05-19 2014-05-06 Eduard N. Lerner Device and methods for enhanced multi-delivery of biologically active substances into an organism and to prevent local irritation
BR122021002471B8 (pt) 2011-03-03 2022-10-25 Impel Neuropharma Inc Dispositivo de distribuição de droga nasal
CN107376071B (zh) 2011-05-09 2021-07-09 英倍尔药业股份有限公司 用于将化合物递送到使用者的上部嗅觉区的喷嘴
EP2991713B1 (de) 2013-04-28 2019-06-19 Impel Neuropharma Inc. Medizinischer einzeldosisbehälter
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
JP6753927B2 (ja) 2015-09-10 2020-09-09 インペル ニューロファーマ インコーポレイテッド 直列形経鼻送達デバイス
CA3081680A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
EP3713628A4 (de) 2017-11-21 2021-08-18 Impel Neuropharma Inc. Intranasale vorrichtung mit tauchrohr
JP2021509677A (ja) 2018-01-05 2021-04-01 インペル ニューロファーマ インコーポレイテッド 精密嗅覚装置によるオランザピンの鼻孔間送達
CA3088942C (en) 2018-01-05 2023-01-03 Impel Neuropharma, Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
US11517548B2 (en) 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
EP3906017A4 (de) 2019-01-03 2022-12-28 Impel Pharmaceuticals Inc. Vorrichtung für nasale wirkstofffreisetzung
US11878109B2 (en) 2019-05-17 2024-01-23 Impel Pharmaceuticals Inc. Single-use nasal delivery device
CN115135363A (zh) * 2019-09-13 2022-09-30 杨森制药公司 艾司氯胺酮的鼻内施用
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
CH539556A (de) 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
DE69031279T2 (de) 1989-12-05 1998-03-19 Ramsey Foundation Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
WO1997016181A1 (en) 1995-11-03 1997-05-09 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
AU8102298A (en) 1999-01-25
IS4516A (is) 1999-01-02
ES2255165T3 (es) 2006-06-16
AU739893B2 (en) 2001-10-25
US6647980B1 (en) 2003-11-18
DE69832070T2 (de) 2006-07-13
ATE307676T1 (de) 2005-11-15
EP0991479A1 (de) 2000-04-12
DK0991479T3 (da) 2006-03-13
CA2298596A1 (en) 1999-01-14
WO1999001229A1 (en) 1999-01-14
EP0991479B1 (de) 2005-10-26

Similar Documents

Publication Publication Date Title
ATE307676T1 (de) Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region
Tartara et al. Vigabatrin in the treatment of epilepsy: a double‐blind, placebo‐controlled study
NO20001087D0 (no) Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer
ATE222495T1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
NL990012I1 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
EP1242013A4 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
BR0108730A (pt) Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados
DE69518334T2 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
DE69306379T2 (de) Inhalierbare arzneimittel
NO890186L (no) Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer.
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
KR930019224A (ko) 유산 위험 치료제
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
CA3178758A1 (en) Treatment of adjustment disorders
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
RU97116821A (ru) Способ лечения респираторных заболеваний
TH66360A3 (th) องค์ประกอบและวิธีการเกี่ยวกับการรักษาโรคภูมิแพ้
KR910005856A (ko) 호흡기 질환 치료용 제약 조성물
RU98109932A (ru) Применение 1-(2-нафт-2-илэтил)-4-(3-трифторметилфенил)-1,2,3,6-тетрагидропиридина для получения лекарственных средств, предназначенных для лечения бокового амиотрафического склероза
EP1690531A3 (de) Dosierungsform und Verfahren zur Verabreichung von einem Wirkstoff

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LYFJATHROUN BIOPHARMACEUTICALS HF., REYKJAVIK, IS

8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8331 Complete revocation
8380 Miscellaneous part iii

Free format text: DIE ZURUECKNAHME VOM 04.06.2009 WURDE GELOESCHT.